Pairwise comparison of levalbuterol versus racemic albuterol in the treatment of moderate-to-severe asthma.
Pleskow WW, Nelson HS, Schaefer K, Claus R, Roach JM.
Pleskow WW, et al. Among authors: nelson hs.
Allergy Asthma Proc. 2004 Nov-Dec;25(6):429-36.
Allergy Asthma Proc. 2004.
PMID: 15709454
Clinical Trial.
The patients received nebulized levalbuterol (0.63 or 1.25 mg), racemic albuterol (1.25 or 2.5 mg), or placebo t.i.d. for 4 weeks. The primary endpoints, published in Nelson HS, Bensch G, Pleskow WW, et al. Improved bronchodilation with levalbuterol compared with ra …
The patients received nebulized levalbuterol (0.63 or 1.25 mg), racemic albuterol (1.25 or 2.5 mg), or placebo t.i.d. for 4 weeks. The prima …